2. Cost Of Capital
2.1 It is a fallacy to suggest that pre-emption rights affect the cost of capital to a company. The dividend, should a company choose to pay one, is only one component of the total return to shareholders which determines the equity cost of capital. Furthermore, the discount in a rights issue does not affect either the cost of capital or shareholders' wealth. It makes no difference to an existing shareholder whether new shares issued by way of rights are issued at a deep discount to the market price, at a modest discount or at the market price itself. A rights issue is essentially an issue of shares at the market price, combined with a scrip issue. All earnings, assets and dividends per share should be adjusted to take account of this scrip element, and this is fully recognised by institutional investors. The discount should only be of relevance to an underwriter, who decides at what price level he is prepared to give the company a guarantee that funds will be available.
2.2 It is asserted by some that potential new investors overseas will be prepared to buy shares at a narrower discount than existing UK shareholders and that, as a consequence, rights issues prevent the establishment of an international share register. However, any discount represents a transfer of value from, and therefore a cost to, existing shareholders. We believe that potential new investors can always buy shares in the market and should not have preferential access to new and usually cheaper shares. Furthermore, long experience demonstrates that shares placed at a discount with new investors overseas usually flow back to their dominant domestic market.